alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO				SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Jacek Oscilowicz, President & Chief Executive Officer and Chief Financial Officer of Britton International Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:				            (1)    The Annual Report on Form 10-KSB of the Company for the year ended April 30, 2006 (the “Report”) fully complies with the requirements of § 13(a) or 15(d) of the Securities Exchange Act of 1934; and				            (2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the periods covered in the Report.*/s/ Jacek Oscilowicz*Jacek Oscilowicz				President & CEOMay 26, 2006*/s/ Jacek Oscilowicz*Jacek Oscilowicz				Chief Financial OfficerMay 26, 2006				A signed original of this written statement required by § 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

****

----
Exhibit 32.2 

CERTIFICATION PURSUANT TO 

18 U.S.C. SECTION 1350, 

AS ADOPTED PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

In connection with the Annual Report of Atlas America Public #14-2005 (A) L.P. (the “Partnership”) on Form 10-K/A for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sean P. McGrath, Chief Financial Officer of the General Partner, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 

|   | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|                                                |
|------------------------------------------------|
| /s/ SEAN P. MCGRATH                            |
| Sean P. McGrath                                |
| Chief Financial Officer of the General Partner |
| September 11, 2015                             |
<PAGE>   1


                              FORM OF LEGAL OPINION

                                  July 8, 1999

Rockford Corporation
648 South River Drive
Tempe, Arizona  85281

         Re:      Registration Statement on Form S-1 (No. 333-79285)

Gentlemen:


                  In connection with the registration under the Securities Act
of 1933, as amended, of 3,895,998 shares of Common Stock, par value $0.01 per
share, of Rockford Corporation (the "Company"), including 508,174 shares as to
which the Underwriters have the option to purchase to cover overallotments, if
any, we have examined the Registration Statement on Form S-1 filed by you with
the Securities and Exchange Commission on May 26, 1999 (No. 333-79285), as
amended through the date hereof (the "Registration Statement"), corporate
records, certificates of public officials, Company officers and such other
documents as we deemed appropriate or necessary for the purpose of rendering
this opinion.



                  Based on the foregoing, it is our opinion that the 3,895,998
shares of Common Stock of the Company covered by the Registration Statement have
been duly authorized and, when the 3,895,998 shares to be sold by the Company
and the Selling Stockholders identified therein have been issued and sold in
accordance with the terms set forth in the Registration Statement, will be
validly issued, fully paid and non-assessable.


                  We consent to the filing of this opinion as an exhibit to the
Registration Statement, and to the reference to our firm under the caption
"Legal Matters" in the Prospectus contained in the Registration Statement.

                                Very truly yours,




                                STEPTOE & JOHNSON
EXHIBIT 99


              JUNIATA VALLEY FINANCIAL CORP. ANNOUNCES 2003 RESULTS


Mifflintown, PA - Francis J. Evanitsky, President & CEO of the Juniata Valley
Financial Corp. recently announced the operating results for 2003. Earnings for
the year were reported at $5,647,000 compared to $5,015,000 for the year 2002.
This represents an increase of 12.60%. On an earnings per share basis, the year
2003 showed $2.47 per share in earnings versus $2.15 per share in 2002, an
increase of 14.88%.

Despite a sluggish economy in our market area, Total Assets grew to $387,780,000
in 2003 from $375,735,000 in 2002. Total Net Loans outstanding reached an all
time high in 2003, closing the year at $249,960,000 compared to $235,497,000 at
year end 2002, an increase of $14,463,000 or 6.14%. Deposits increased to
$332,984,000 in 2003 from $322,619,000 in 2002.

As a result of the aforementioned loan and deposit growth as well as a
significant increase in other income, and the resulting increase in Net Income,
the Juniata Valley Financial Corp. recorded a ROAA (Return on Average Assets) of
1.46% for 2003 versus 1.37% in 2002. Additionally, ROAE (Return on Average
Equity) increased to 11.86% in 2003 versus 10.85% in 2002.

Evanitsky commented "We are pleased with the results of 2003. However, it was an
extremely challenging year and it appears that 2004 will be just as
challenging."

The Juniata Valley Bank was chartered in 1867 and has twelve offices serving
Juniata, Mifflin, Perry and Huntingdon counties. More information regarding the
Juniata Valley Bank can be found online at www.jvbonline.com.
Exhibit 4.4 - Notice of Transfer



Exhibit 4.4


NOTICE OF TRANSFER PURSUANT

TO REGISTRATION STATEMENT


U.S. Bank National Association

550 S. Hope Street, Suite 500

Los Angeles, California 90071

Attention: Corporate Trust Services


Quantum Corporation

1650 Technology Drive, Suite 800

San Jose, California, 95110

Attention: General Counsel


 


Re:    Quantum Corporation (the "Company") 4.375% Convertible Subordinated Notes due 2010 (the "Notes")


Dear Sirs:


Please be advised that                    has transferred
$                aggregate principal amount of the above-referenced Notes or the Company's Common Stock, issued on conversion of the Notes, pursuant to the Registration Statement on
Form S‐3 (File No.    ‐        ) filed by the Company.


We hereby certify that the prospectus delivery requirements, if any, of the Securities Act of 1933, as amended, have been satisfied with respect to the transfer described above and that the above-named beneficial owner of the
Notes or Common Stock is named as a selling securityholder in the Prospectus dated                , 2003 or in amendments or supplements thereto, and that the aggregate principal amount of the
Notes or number of shares of Common Stock transferred are [a portion of] the Notes or Common Stock listed in such Prospectus as amended or supplemented opposite such owner's name.


 


                                                                                                     Very
truly yours,


                                                                                                     
(Name)


                                                                                                     By:
                                          


                                                                                                     
    (Authorized Signature)


Dated:
February 8, 1955

No. 58772.

Suit 4831.

#### United States *v.*Carey & Skinner, Inc.

C. D. 1634. (Appeal dismissed December 10, 1954.)
EXHIBIT 32.2

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Cougar Biotechnology, Inc. does hereby certify that, to his knowledge:



| | (a) | the Annual Report on Form 10-KSB of Cougar Biotechnology, Inc. for the year ended December 31, 2006 (the Report) fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (b) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Cougar Biotechnology, Inc.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------



|                    |  |     |  |                                                       
|------------------- |  | --- |  | ------------------------------------------------------
|Date: April 2, 2007 |  | By: |  | /s/    CHARLES R.
EYLER                               
|                    |  |     |  | Charles R. Eyler Treasurer and Vice President, Finance
Exhibit 32


                                  CERTIFICATION

The undersigned certifies pursuant to 18 U.S.C.ss.1350, that:

(1) The accompanying Quarterly Report on Form 10-QSB for the period ended June
30, 2003, fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

(2) The information contained in the accompanying Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


Date: August 7, 2003                                     /s/ James Carbonari
                                                         -------------------
                                                         President and CEO


                                                         /s/ Gregory P. Jensen
                                                         ---------------------
                                                         Chief Financial Officer


















                                       21
# C o u rt o f

A p p ea ls

o f t h e S t a te o f

G eo rg ia

ATLANTA,_ M a y 2 4

, 2 0 2 2

_ __ _ _ _ _

Th e Co u rt

o f Ap p ea l s h er eb y p a s s es t h e f

o ll owi n g o r der :

A2 2 E0 05 4 . I N THE I NTEREST OF S. H. et a l . (FATHER).

Up o n co n s i d era tion of th e Ap pel l an t ’ s m o t i on fo r an ex t en s i on o f t i m e i n wh i ch

t o fi l e a d i s cret i o nary ap p l i cat i o n

, t h e s a m e i s h ereb y GRANTED. A p p el lan t s h al l

h av e u n t i l J u n e 8 , 2 0 2 2 , i n wh i ch t o fi l e t h e ap pl i cat io n

.

C o u r t o f A p p e a l s o f t h e S t a t e o

f G e o r g ia

C le r k ’ s O f f i c e

, A t la n t a

,

_

M a y 2 4

, 2 0 2 2

I c e r ti fy t h a t t h e a b o v e i s a t r u e e x t r a c t f r o m

t h e m i n u t e s o

f t h e C o u r t o

f A p p e a l s o f G e o r g i a

.

W i t n e s s m y s i g n a t u r e a n d th e s e a l o

f s a i d c o u r t

h e r e t o a f f i x e d t h e d a y a n d y e a r l a s t a b o v e w r i t t e n

.

, C l e r k

.
No. 51883.

#### B. R. Anderson & Co. *v.*United States,

protests 946676-G, etc. (Seattle).

Opinion by

Tilson, J.

It was stipulated that the merchandise consists of imitation gut similar in all material respects to that the classification of which was involved in *Bush*v. *United States*(34 C. C. P. A. 17, C. A. D. 338). Upon the established facts and following the cited authority, the claim of the plaintiff was sustained.
**EXHIBIT 12.1**

**SECTION 302 CERTIFICATION**

I, Gao Ren, certify that:

1.   I have reviewed this Shell Company Report on Form 20-F/A of China Linen Textile Industry, Ltd.

2.   Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; 

4.

The company's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

a.  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

b.  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principals; 

c.  Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

d.  Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting: and 

5.

The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions):

a.  All significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and

b.  Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal controls over financial reporting.
Exhibit 31.1
 
 **CERTIFICATION**
 
 
 I, Jeffrey Staszak, certify that:
 
 1. I have reviewed this quarterly report on Form 10-Q of Volterra Semiconductor Corporation;
 
 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 
 a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrants fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
 5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):
 
 a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
 b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 ****Date: September 8, 2004
By:
/s/ Jeffrey StaszakJeffrey Staszak
Chief Executive Officer
INITIAL REVIEW ENGINEERING REPORT ID Number: P-04-0153

ENGINEER: Hall/WRL/CLH PV (kg/yr):
SUBMITTER:

USE:

OTHER USES:

MSDS: Label: General Eqp.: Respirator:
Health Effects: TLV/PEL (PMN or raw materials):

CRSS (12/11/2003): Chemical Category:
Molecular Formula:

VP:
S-H 2 O:
MW: Phys State:

Consumer Use:

SAT (12/12/2003): Groundwater: Health:

Eco: PBT Potential:

OCCUPATIONAL EXPOSURE RATING:

ASSUMPTIONS:

POLLUTION PREVENTION CONSIDERATIONS:

EXPOSURE-BASED REVIEW?INITIAL REVIEW ENGINEERING REPORT ID Number: P-04-0153

PROC/USE:

Site/Location: Days/yr:

Process Description:

ENVIRONMENTAL RELEASES (Eqpt. cleaning, container residue, etc.):

WATER: 1) 10.4 kg/site-day over Days/year
and 2) Worst: 2.4 kg/site-day over Days/year Typical: 0.24 kg/site-day over Days/year

from:

to: Basis:

AIR: negligible

OCCUPATIONAL EXPOSURE Tot. # of workers: Days/yr:

Inhalation: mg/day over Days/yr Number of workers with inhalation exposure: Basis:

Inhalation Monitoring Data Review 1) Uncertainty (estimate based on model, regulatory limit, or data not specific to industry): 2)a) Exposure level > 1 mg/day?
OR b) Hazard rating for health of 2 or greater? **Inhalation monitoring data desired?**

Dermal:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 75606)    
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center for Advancing Translational Sciences Special Emphasis Panel; CTSA Training Application Review.                    

*Date:*                         February 8, 2024.                    

*Time:*                         10:00 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Center for Advancing Translational Sciences, National Institutes of Health,  6701 Democracy Boulevard Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Alumit Ishai, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1016, Bethesda, MD 20892, (301) 496-9539,                         *alumit.ishai@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS)

Dated: October 30, 2023.

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-24278 Filed 11-2-23; 8:45 am]

BILLING CODE 4140-01-P
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 17-20425

Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

KEON KERVIN JACKSON,

Defendant-Appellant

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 4:15-CR-264-2

Before DAVIS, CLEMENT and COSTA, Circuit Judges.

PER CURIAM:*

The attorney appointed to represent Keon Kervin Jackson has moved for 

leave to withdraw and has filed a brief in accordance with Anders v. California, 

386 U.S. 738 (1967), and United States v. Flores, 632 F.3d 229 (5th Cir. 2011). 

Jackson has not filed a response. We have reviewed counsel’s brief and the 

relevant portions of the record reflected therein. We concur with counsel’s 

assessment that the appeal presents no nonfrivolous issue for appellate review. 

 

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not 

be published and is not precedent except under the limited circumstances set forth in 5TH 

CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

March 6, 2018

Lyle W. Cayce

Clerk

 Case: 17-20425 Document: 00514374457 Page: 1 Date Filed: 03/06/2018
No. 17-20425

2

Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is 

excused from further responsibilities herein, and the APPEAL IS DISMISSED. 

See 5TH CIR. R. 42.2.

 Case: 17-20425 Document: 00514374457 Page: 2 Date Filed: 03/06/2018